PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

NCT04404361 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

200

Enrollment

INDUSTRY

Sponsor class

Stopped decision to close enrollment early

Conditions

COVID19
COVID-19
COVID

Interventions

DRUG: Pacritinib
DRUG: Placebo

Sponsor

CTI BioPharma